[1]姜亚男,张明瑛.丙种球蛋白治疗川崎病患儿的效果及对抗血小板聚集相关因子免疫功能的影响[J].医学信息,2022,35(11):118-120.[doi:10.3969/j.issn.1006-1959.2022.11.030]
　JIANG Ya-nan,ZHANG Ming-ying.Effect of Gamma Globulin on Immune Function of Antiplatelet Aggregation Related Factors in Children with Kawasaki Disease[J].Medical Information,2022,35(11):118-120.[doi:10.3969/j.issn.1006-1959.2022.11.030]
点击复制

丙种球蛋白治疗川崎病患儿的效果及对抗血小板聚集相关因子免疫功能的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年11期
页码:
118-120
栏目:
论著
出版日期:
2022-06-01

文章信息/Info

Title:
Effect of Gamma Globulin on Immune Function of Antiplatelet Aggregation Related Factors in Children with Kawasaki Disease
文章编号:
1006-1959（2022）11-0118-03
作者:
姜亚男; 张明瑛
（北京市顺义区医院儿科，北京 101300）
Author(s):
JIANG Ya-nan; ZHANG Ming-ying
(Department of Pediatrics,Beijing Shunyi Hospital,Beijing 101300,China)
关键词:
丙种球蛋白; 川崎病; 炎症反应; 抗血小板聚集; 免疫功能
Keywords:
Gamma globulin; Kawasaki disease; Inflammatory response; Anti-platelet aggregation; Immune function
分类号:
R725.4
DOI:
10.3969/j.issn.1006-1959.2022.11.030
文献标志码:
A
摘要:
目的 研究丙种球蛋白治疗川崎病（KD）患儿的效果及对抗血小板聚集相关因子及免疫功能的影响。方法 选取2019年11月-2021年10月北京市顺义区医院儿科收治的72例KD患儿，按照随机数字表法分为对照组与观察组，每组36例。对照组给予阿司匹林治疗，观察组在对照组基础上联合丙种球蛋白治疗。比较两组症状消退时间、住院时间、炎症因子[C反应蛋白（CRP）、肿瘤坏死因子（TNF-α）]、抗血小板聚集相关因子[血小板计数（PLT）、白细胞计数（WBC）、红细胞沉降率（ESR）]、免疫功能指标（CD3+、CD4+、CD8+）。结果 观察组症状消退时间及住院时间短于对照组（P＜0.05）；观察组CRP、TNF-α、PLT、WBC、ESR、CD4+低于对照组，CD3+、CD8+高于对照组（P＜0.05）。结论 丙种球蛋白可缩短KD患儿的康复时间，下调炎症反应，提高患儿的抗血小板聚集作用及免疫功能。
Abstract:
Objective To study the effect of gamma globulin in the treatment of children with Kawasaki disease (KD) and its effect on platelet aggregation related factors and immune function.Methods A total of 72 children with KD admitted to Department of Pediatrics of Shunyi District Hospital of Beijing from November 2019 to October 2021 were randomly divided into control group and observation group, with 36 cases in each group. The control group was treated with aspirin, and the observation group was treated with gamma globulin on the basis of the control group. The symptom regression time, hospitalization time, inflammatory factors [C-reactive protein(CRP), tumor necrosis factor-α(TNF-α)], anti-platelet aggregation related factors [platelet count (PLT), white blood cell count (WBC) and erythrocyte sedimentation rate (ESR)], immune function indexes (CD3+, CD4+, CD8+) were compared between the two groups.Results The symptoms subsided time and hospitalization time in the observation group were shorter than those in the control group (P<0.05). The levels of CRP, TNF-α, PLT, WBC, ESR and CD4+ in the observation group were lower than those in the control group, and CD3+ and CD8+ were higher than those in the control group (P<0.05).Conclusion Gamma globulin can shorten the recovery time of children with KD, down-regulate inflammation, and improve the anti-platelet aggregation effect and immune function.

参考文献/References:

[1]沈杨,单晶,刘光辉,等.丙种球蛋白联合阿司匹林肠溶片治疗川崎病的临床研究[J].中国临床药理学杂志,2017,33(23):2347-2350.[2]马飞艳,王娟,樊萍.川崎病患儿血清趋化素和缺血修饰清蛋白水平与冠状动脉损伤的相关性及在治疗中的应用价值[J].现代检验医学杂志,2021,36(3):72-75.[3]Dhanrajani A,Yeung RSM.Revisiting the role of steroids and aspirin in the management of acute Kawasaki disease[J].Curr Opin Rheumatol,2017,29(5):547-552.[4]王春晖,赵宏芳,杨洁,等.丙种球蛋白对川崎病患儿炎症反应氧化应激及基质金属蛋白酶的影响[J].山西医药杂志,2020,49(2):133-136.[5]Lo MS,Newburger JW.Role of intravenous immunoglobulin in the treatment of Kawasaki disease[J].Int J Rheum Dis,2018,21(1):64-69.[6]Miyata K,Kaneko T,Morikawa Y,et al.Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study[J].Lancet Child Adolesc Health,2018,2(12):855-862.[7]Ayusawa M,Sonobe T,Uemura S,et al.Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition)[J].Pediatr Int,2005,47(2):232-234.[8]程相范.不同剂量丙种球蛋白联合阿司匹林治疗小儿川崎病临床疗效[J].实用中西医结合临床,2019,19(2):41-43.[9]张英谦,郝京霞,李博,等.静脉用丙种球蛋白治疗川崎病的时机和临床效果分析[J].中国医药,2021,16(2):204-207.[10]马光举.丙种球蛋白联合阿司匹林治疗小儿川崎病临床观察[J].济宁医学院学报,2018,41(5):329-331.[11]欧阳冰,唐林芬,戚胡敏,等.甲泼尼龙联合丙种球蛋白治疗川崎病疗效观察[J].新乡医学院学报,2018,35(10):907-909,913.[12]王新芳,黄先玫,王跃生,等.大剂量丙种球蛋白联合阿司匹林对川崎病患儿血管内皮因子和抵抗素及内脂素的影响[J].中华全科医学,2018,16(10):1674-1676.[13]马春伟.不同剂量丙种球蛋白联合阿司匹林治疗小儿川崎病的临床疗效评价[J].黑龙江医药,2018,31(4):789-791.[14]赵有丽,刘彩霞.阿司匹林联合大剂量丙种球蛋白治疗小儿川崎病的疗效及对血清脑利钠肽指标的影响[J].川北医学院学报,2018,33(2):166-168.[15]卢筱蓉.大剂量丙种球蛋白联合阿司匹林治疗小儿川崎病的临床效果[J].中国卫生标准管理,2017,8(28):108-111.[16]赖志光,戴道华.丙种球蛋白联合阿司匹林治疗小儿川崎病的临床疗效观察[J].中国医药科学,2015,5(9):88-89,101.[17]Wang WT,He M,Shimizu C,et al.Inflammasome Activation in Children With Kawasaki Disease and Multisystem Inflammatory Syndrome[J].Arterioscler Thromb Vasc Biol,2021,41(9):2509-2511.[18]程力平.丙种球蛋白注射剂联合阿司匹林肠溶片治疗川崎病的临床研究[J].中国临床药理学杂志,2017,33(15):1425-1427.[19]钱颖,王有成,方晓丹,等.大剂量丙种球蛋白联合阿司匹林对川崎病患儿T淋巴细胞亚群、血管内皮因子、炎症因子水平的影响[J].中华全科医学,2017,15(3):454-456.[20]杨莹,张静.激素与静脉丙种球蛋白及其联合应用治疗静脉丙种球蛋白无反应川崎病的回顾性对照研究[J].中国循证儿科杂志,2016,11(4):265-269.[21]Mohammadzadeh I,Noei S,Babazadeh K,et al.Comparison of early and late intravenous gamma globulin treatment of Kawasaki disease on fever and cardiovascular complications[J].Caspian J Intern Med,2016,7(3):211-216.

相似文献/References:

[1]覃 艺,邓燕艺,赖昌生,等.手足口病患儿体内免疫球蛋白、补体、C反应蛋白及刺激分析CD80、CD86水平的临床意义及其与丙种球蛋白治疗疗效的关系[J].医学信息,2018,31(02):63.[doi:10.3969/j.issn.1006-1959.2018.02.022]
　Qin Yi,DENG Yan-yi,LAI Chang-sheng,et al.Clinical Significance of Immunoglobulin,Complement,C-reactive Protein and CD80,CD86 in Children with Hand-foot-mouth Disease and their Relationship with Therapeutic Effect of Gamma Globulin[J].Medical Information,2018,31(11):63.[doi:10.3969/j.issn.1006-1959.2018.02.022]
[2]孙昌瑞,冯 林.心肌标志物联合检测对川崎病早期诊断的临床意义[J].医学信息,2019,32(08):113.[doi:10.3969/j.issn.1006-1959.2019.08.032]
　SUN Chang-rui,FENG Lin.Clinical Significance of Combined Detection of Myocardial Markers in Early Diagnosis of Kawasaki Diseases[J].Medical Information,2019,32(11):113.[doi:10.3969/j.issn.1006-1959.2019.08.032]
[3]黄 铃,孙 冰,蔡金美,等.维生素D治疗川崎病的疗效及其对血清促炎因子的影响[J].医学信息,2019,32(18):81.[doi:10.3969/j.issn.1006-1959.2019.18.025]
　HUANG Ling,SUN Bing,CAI Jin-mei,et al.Therapeutic Effect of Vitamin D on Kawasaki Disease and Its Effect on Serum Pro-inflammatory Factors[J].Medical Information,2019,32(11):81.[doi:10.3969/j.issn.1006-1959.2019.18.025]
[4]喻 明,李 莹,王秀容.甲泼尼龙联合丙种球蛋白治疗抗NMDAR型脑炎的疗效及对患者精神症状的影响[J].医学信息,2021,34(15):159.[doi:10.3969/j.issn.1006-1959.2021.15.044]
　YU Ming,LI Ying,WANG Xiu-rong.Efficacy of Methylprednisolone Combined with Gamma Globulin in the Treatment of Anti-NMDAR Encephalitis and Its Effect on Patient’s Mental Symptoms[J].Medical Information,2021,34(11):159.[doi:10.3969/j.issn.1006-1959.2021.15.044]
[5]林 婷.纤维支气管镜肺泡灌洗联合丙种球蛋白治疗小儿重症肺炎的疗效及对炎症因子的影响[J].医学信息,2022,35(22):79.[doi:10.3969/j.issn.1006-1959.2022.22.014]
　LIN Ting.Therapeutic Effect of Bronchoalveolar Lavage Combined with Gamma Globulinon Severe Pneumonia in Children and its Influence on Inflammatory Factors[J].Medical Information,2022,35(11):79.[doi:10.3969/j.issn.1006-1959.2022.22.014]
[6]张晓和,程 雪,周文娟,等.基于网络平台的追踪延伸护理在儿科川崎病患儿中的应用效果[J].医学信息,2023,36(23):161.[doi:10.3969/j.issn.1006-1959.2023.23.041]
　ZHANG Xiao-he,CHENG Xue,ZHOU Wen-juan,et al.Application Effect of Tracking Extended Nursing Based on Network Platform in Children with Kawasaki Disease in Pediatrics Department[J].Medical Information,2023,36(11):161.[doi:10.3969/j.issn.1006-1959.2023.23.041]
[7]刘素香,黄静娴,黄 娟,等.肿瘤坏死因子-α、白细胞介素-1B、γ-干扰素水平在儿童川崎病合并冠状动脉病变中的价值[J].医学信息,2024,37(20):159.[doi:10.3969/j.issn.1006-1959.2024.20.034]
　LIU Suxiang,HUANG Jingxian,HUANG Juan,et al.Value of Tumor Necrosis Factor-α, Interleukin-1B and Interferon-γ Levels in Children with Kawasaki’s Disease Complicated with Coronary Artery Disease[J].Medical Information,2024,37(11):159.[doi:10.3969/j.issn.1006-1959.2024.20.034]
[8]刘海珍.丙种球蛋白应用时间对川崎病患儿退热时间及冠状动脉损伤的影响[J].医学信息,2022,35(16):73.[doi:10.3969/j.issn.1006-1959.2022.16.016]
　LIU Hai-zhen.The Effect of Application Time of Intravenous Immune Globulin on Fever Clearance Time and Coronary Artery Lesion for Kawasaki Disease[J].Medical Information,2022,35(11):73.[doi:10.3969/j.issn.1006-1959.2022.16.016]

更新日期/Last Update: 1900-01-01